English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The combined 3rd conference of the Romanian Association of Immuno-dermatology and 37th conference of the Romanian Society of Immunology was held in Bucharest between September 19 and 22, 2019. The presentations were included in a call for a special issue on immunological processes involved in skin diseases and in cancer. The following articles are presented in this special issue: In the article ‘Reinforcing involvement of NK cells in psoriasiform dermatitis animal model’, Surcel et al (1) used the imiquimod-based mouse model of psoriasiform dermatitis and NK cell complex phenotype patterns from peripheral blood and spleen were investigated. The maturation markers (CD11b, CD43, CD27, KLRG1) were found increased in NK cells, in periphery and spleen, while CD49b+NK1.1+ was found significantly lower, and these changes were associated with the severity of the disease. Porumb-Andrese et al (2) examined the association between personality type, an affective distress profile and the quality of life in patients with psoriasis versus that of patients with cardiovascular disease. The authors demonstrated that it is necessary to include items evaluating the patients' affective profiles and personality in the assessment protocols of these diseases. Grajdeanu et al (3) summarized in their review article entitled ‘Imaging techniques in the diagnosis and monitoring of psoriasis’ the current developments in the field of psoriasis non-invasive imaging techniques, such as dermoscopy, conventional ultrasound and high frequency ultrasonography (HFUS), videocapillaroscopy (VC), reflectance confocal microscopy (RCM), optical microangiography (OMAG), laser Doppler imaging (LDI), multiphoton tomography (MPT) or optical coherence tomography (OCT). In the study ‘High-frequency ultrasonography of psoriatic skin: A non-invasive technique in the evaluation of the entire skin of patients with psoriasis: A pilot study’, Șomlea et al (4) intended to evaluate lesional and non-lesional skin from psoriatic patients with the use of high-frequency ultrasonography (HFUSG), focusing on the immune-induced inflammation and skin thickness. The authors considered that skin HFUSG should be used as a quantitative method in the clinical evaluation of the patients with psoriasis and may aid as an objective means of assessing inflammation in lesional skin. Mocanu et al (5) examined the reasons for non-adherence to anti‐TNFα agents (Infliximab, Adalimumab and Etanercept) used for the treatment of 84 cases with moderate-severe psoriasis, proving that the highest adherence rate was recorded with Adalimumab (80.8%), followed by Infliximab (76.5%) and Etanercept (70.9%). In the study by Stanca et al (6), the authors aimed to identify and describe anatomical and functional changes in the short‐term (1‐3 months) and medium‐term (6‐12 months) following intravitreal injections of bevacizumab (Avastin, Genentech) in patients with choroidal neovascularization (CNV) in the context of an exudative form of age-related macular degeneration (AMD). The authors proved that the use of bevacizumab in the treatment of subretinal neovascular membranes was effective and safe in the shortand medium-term, with the improvement of BCVA and the reduction of macular edema in a significant number of cases. Boia et al (7) aimed to evaluate and compare the clinical and microbiological effects of two different regimens of amoxicillin (AMX) and metronidazole (MTZ), combined Correspondence to: Dr Daniel Boda, Dermatology Research Laboratory, ‘Carol Davila’ University of Medicine and Pharmacy, 8 Eroii Sanitari Avenue, 050474 Bucharest, Romania E-mail: daniel.boda@yahoo.com

experimental and therapeutic medicine

[Editorial] Highlights of the 3rd conference of the Romanian Association of Immuno‑Dermatology and the 37th conference of the Romanian Society of Immunology held in Bucharest between September 19 and 22, 2019